Potassium
(K) channels are important regulators of cellular physiology and can themselves be modulated by phosphorylation.
We have investigated the potential protein kinase A (PKA) regulation of mKv1 .l, a mouse Shaker-like K channel gene, when it is expressed in stably transfected Chinese hamster ovary (CHO) cell lines. Whole-cell patchclamp records show that expression of mKvl.l gives rise to a rapidly activating, sustained K+ current, referred to classically as a delayed rectifier-type current. In order to study the effects of PKA, we compared cell lines transfected with mKv1 .l alone with lines cotransfected with both mKv1 .l and a plasmid encoding a dominant negative mutation in the regulatory subunit of PKA. These mutant regulatory subunits bind to endogenous catalytic subunits of PKA but do not respond to CAMP, thereby causing a chronic reduction in the basal PKA activity in these cells. We found that mKvl.1 current kinetics are unaltered but current density is 3.4-fold higher in the cell lines expressing mutant regulatory subunit than in lines expressing only mKvl.1. RNase protection assays indicate that levels of the specific RNA for mKvl.1 are increased almost twofold in the lines expressing mutant regulatory subunit over the lines expressing mKv1 .l only. Further, the levels of mKvl.1 protein, assayed using an mKv1 .l channel-specific antibody, are increased by almost a factor of 3 between the two types of cell lines. These results suggest that PKA can regulate mKvl.1 channel expression by changing steady-state levels of RNA and by other posttranscriptional mechanisms. [Key words: potassium channel, delayed rectifier, phosphorylation, protein kinase A, channel regulation, gene expression]
Voltage-gated potassium channels are a diverse family of structurally related proteins, each with unique kinetics, pharmacology, and tissue distribution. Molecular cloning and expression of a number of K channel genes have provided new insight into channel structure and the functions of various domains of the channel (Miller, 199 1) . Relatively little is known, however, about the mechanisms regulating K channel gene expression or those regulating assembly, distribution, and stability of the channel proteins. These processes are likely to be important in determining the contribution of each channel type to the various K+ currents measured in cells where each gene is expressed.
The first mammalian K channel genes were isolated from mouse brain (Tempel et al., 1988) and from rat brain (Baumann et al., 1988) based on the similarity of these genes to the Drosophila Shaker K channel genes (Jan and Jan, 1989; Salkoff et al., 1992) . Recently, these genes have been designated Kv 1.1 to indicate their ionic selectivity, voltage sensitivity, subfamily membership, and order of isolation (Chandy et al., 199 1) . Functional expression of the rat brain clone in Xenopus oocytes and in stably transfected mammalian Sol8 cells demonstrated that rKvl.1 (previously RCKl) currents were rapidly activating, with inactivation over tens of seconds (Stuehmer et al., 1988; Christie et al., 1989; Koren et al., 1990) . Similar kinetics are observed when mKvl.1 (previously referred to as MBKl) is expressed in Xenopus oocytes (Hopkins and Tempel, 1992) . The Kv 1.1 gene sequences from all mammalian species studied to date predict a consensus PKA phosphorylation site in the carboxyl end of the channel subunit. Similar sites are observed in other related K channels Drewe et al., 1992) .
A large body of work has demonstrated that kinase activity, in particular protein kinase A (PKA) activity, is important in gene regulation, development, learning, and at times when the nervous system undergoes plastic remodeling (Montminy et al., 1989; Mayford et al., 1992) . However, fewer studies have reported on the regulation of expression of ion channels. Modulation of Ca channels by hormone action in cardiac tissue has been shown to upregulate current by direct PKA-mediated phosphorylation of the channel (Trautwein and Hescheler, 1990) . In stably transfected CHO cells expressing Na channel cDNA, acute stimulation of PKA activity suppresses Na+ current. Removal of basal PKA activity in those cells upregulates channel expression by a posttranscriptional mechanism (Li et al., 1992) . In contrast, during NGF-mediated PC 12 cell differentiation, the endogenous Na+ current is upregulated by CAMP stimulation via a pathway that requires a functional PKA catalytic subunit (Kalman et al., 1990) . Reduction of basal PKA activity in this system blocks functional Na channel expression although Na channel transcript is upregulated (Ginty et al., 1992) .
Physiological evidence suggests that voltage-gated K channels are also modulated by hormones in many tissues. Indeed, PKA modulation of delayed rectifier-type K+ currents has been shown clearly in heart and in lymphocytes (Giles et al., 1989; Soliven and Nelson, 1990) . In cardiac tissue, however, the molecular species of K channel(s) modulated by PKA is not known since several different K channel genes with potential PKA phos-phorylation sites are expressed in cardiac tissue (Roberds and Tamkun, 199 1) . In addition, a unique, small K channel gene that is expressed in heart and involved in the establishment of a slowly activating K+ current, IsK, has been shown to be modulated by PKA-induced insertion of channels into the membrane of the Xenopus oocyte expression system (Blumenthal and Kaczmariek, 1992) .
Here we address the question of PKA regulation of the expression of a cloned K channel cDNA, mKvl.l, by using a molecular tool to block endogenous PKA activity. We have stably transfected mKv 1.1 into CHO cells, and also into CHO cells that contain a plasmid encoding a dominant mutant regulatory subunit of PKA (Clegg et al., 1987) . This PKA regulatory subunit has been mutated in both the A and B CAMP binding sites (AB-), and therefore remains constitutively bound to the catalytic subunit of PKA, inactivating the endogenous PKA. We have used this model to study the effects of PKA on expression of mKv 1.1 RNA, protein, and current. Our results suggest that reducing basal PKA activity leads to an increase in mKv 1.1 K+ current via an increase in RNA as well as other posttranscriptional mechanisms.
Materials and Methods
Plasmids. For establishment of the stable cell lines, a fragment of the mKvl.l potassium channel cDNA clone MK9.6 (Tempel et al., 1988) was inserted into the BamHI restriction endonuclease site of pZEM 228 (kindly provided by E. Mulvihill, Zymogenetics Inc., Seattle, WA). The subcloned region of mKv 1.1 extends from the SmaI site 40 base pairs (bp) upstream of the AUG start codon through the Hind111 site downstream from the TAA stop codon. Thus, in this pZEM-mKv 1.1 construct, the coding region of mKvl.1 is placed downstream of a mouse metallothionine promoter with high constitutive activity and upstream of SV40 polyadenylation and termination sequences. In order to generate riboprobes that protect the 5' end of the mKv 1.1 sequence, a252 bp fragment from the SmaI site to the SphI site, encompassing the AUG start codon, was cloned into pBluescript SK+ (Strategene, La Jolla, CA). For riboprobes that protect the 3' end of the mKvl.1 sequence, a 197 bp fragment from BclI to HindIII, including the TAA stop codon, was cloned into pBluescript SK+ (see Fig. 5B ).
Cell culture and transfection. Wild-type CHO cells were maintained using standard tissue culture techniques in RPM1 1640 medium supplemented with 5% fetal bovine serum. 2 mM alutamine. 50 U of oenicillin/ml, and 50 rg of streptomycin/ml. CH&AB-cells containing the mutant regulatory subunit of PKA (kindly provided by the laboratory of Dr. William Catterall, University of Washington) were maintained with the same medium supplemented with 200 &ml hygromycin. Both lines of CHO cells were transfected with 15 hg of pZEMmKvl.1 plasmid DNA bv electroooration usine a Bio-Rad Gene Pulser Transfection Apparatus (Richmond, CA). Twodays after the transfection procedure, G4 18 (Geneticin, GIBCO-Bethesda Research Labs, Gaithersburg, MD) was added to 500 &ml. Established lines were thereafter maintained with G4 18 at 250 &ml. Two days prior to harvest, cells were seeded simultaneously for electrophysiology, RNA preparation, and protein analysis. On the day that the electrophysiology was done, parallel cultures were harvested for RNA and protein analyses.
RNA analysis. In order to isolate total RNA, cells were removed from two T-25 Basks with versene and pelleted in a 50 ml conical centrifuge tube. The cell pellet was rapidly vortexed in 1 ml of 4 M guanidinium thiocyanate and processed under acidic conditions to yield total RNA free from DNA (Chomczynski and Sacchi, 1987) . RNA concentrations were determined by A260 optical density measurements done in duplicate. RNase protection assays were performed on 2.5 or 10 pg of total RNA according to methods in Ausubel et al. (199 1) . Riboprobes were synthesized in the presence of 32P-UTP to a specific activity of 4 x 10' cpm/pg cRNA; 2.5 x lo5 cpm was added to each sample for hybridization. The hybridization mix was incubated at 50°C overnight, digested with RNase A and RNase Tl, phenol extracted, concentrated, and separated on a denaturing 6% acrylamide sequencing gel. The amount of RNA protected in each sample was quantified by PhosphorImager analysis using the Molecular Dynamics scanner at the Fred Hutchinson Cancer Research Center, Image Analysis Laboratory, Seattle, WA.
Protein analysis. For both total protein (Western) blot analysis and immunoprecipitation experiments, cells were incubated in equal volumes of culture medium for 20 hr, one without radioactivity for Westems and one containing 0.1 mCi/ml 3sS-methionine for immunoprecipitation. Cells were then rinsed in culture medium several times, removed by versene treatment, and pelleted in a 50 ml conical. The pellet was resuspended in 1 ml of Tris-saline (TBS; 20 mM Tris-HCl, 100 mM NaCl, pH 7.5) and disrupted in a glass-glass homogenizer. The membrane fraction was separated from the soluble fraction by centrifuging at 15,000 x g for 10 min, and the pellet was resuspended in 1 ml of 1% T&on-X in TBS on ice for 1 hr. After duplicate resuspensions and centrifugations at 15,000 x g for 30 min (4"C), the supematant was saved as the membrane protein fraction. Total protein concentration was determined in duplicate using the DC Protein Assay kit supplied by Bio-Rad Laboratories (Hercules, CA).
For Western blots, 8-10 pg of protein was separated by SDS-PAGE and electrotransferred to either PVDF or nitrocellulose membranes using Protean mini-gel apparati (Bio-Rad). The protein blots were incubated first with polyclonal antibodies developed against a C-terminal peptide ofmKvl.1 (cu-Kvl. 1; residues 427-495; Wang et al., 1993) . The antibody had been adsorption purified twice against an mKvl.2-glutathionine-S-transferase fusion protein-coupled sepharose column. (The mKvl.2 clone is a closely related Shaker-like channel with high sequence homology; this step was used to make the antibody more specific.) The secondary antibody for chemiluminescence was alkaline phosphatase-conjugated goat anti-rabbit IgG, and for color reactions was horseradish peroxidase-conjugated goat anti-rabbit IgG. The substrate for the chemiluminescent reaction was Lumi-Phos 530 (Boehringer Mannheim Corporation, Indianapolis, IN), and for the color reaction was 3,3'-diaminobenzidine.
The Western blot images were densitized and analyzed at the Fred Hutchinson Cancer Research Center, Image Analysis Laboratory.
For immunoprecipitation experiments, either 20 pg protein/cell line or 7 x lo6 cpm/cell line was precleared by incubation with 3 ~1 of preimmune serum for 1 hr at 4°C followed by addition of 30 ul of Protein A-sepharose (2 mg Protein A/ml sepharose) in dilution buffer (0.1% bovine hemoglobin and 0.1% T&on-X in TBS). incubation for 30 min at 4"C, and then centrifugation at 5000 x g for 5 min. Protein was immunoprecipitated by replacing preimmune serum with 3 ~1 of adsorption-purified or-Kv1.1 antibody in the same protocol, with the exception that 10 ~1 of Protein A-sepharose was used. Precipitated protein was washed with dilution buffer three times, twice with TBS, and once with 0.5 M Tris, pH 6.8; 25 ~1 of 5 x sample buffer was added, and the samples were boiled for 10 min and separated using 10% SDS-PAGE. The gel was soaked in fluorography enhancing solution (Entensify, Amersham Corporation, Arlington Heights, IL) and dried on 3 mm filter paper. Blots were placed in a phosphorimager cassette for 5 d, and the image was collected and analyzed at the Fred Hutchinson Cancer Research Center.
Electrophysiology. CHO cells were grown in adherent culture at low density (5-10% confluency) on 35 mm plastic tissue culture dishes. For recording, a Sylgard (Dow Chemical, Midland, MI) chamber was constructed inside the dish, such that the total bath volume was 0.2 ml. Perfusion of the bath was achieved by continuous gravity flow, and changes in the perfusion solution were made by switching a four-way valve. The approximate dead volume between solutions was 0.3 ml, and the bath flow was approximately 0.5 ml/min. Pipette solution was (mM) K-aspartate, 100; KCl, 20; MgCl,, 3; K,EGTA, 10; K,HEPES, 25; ATP, 0.3; GTP, 0.1; pH 7.4 with KOH. Standard bath Ringer solution was (mM) NaCl, 140; KCl, 2.5; CaCl,, 3; MgCl,, 1; Na,HEPES, 10; pH 7.4 with NaOH. For 0 Na experiments the NaCl was replaced by equimolar N-methyl-D-glucamine (NMDG), and HCl was used for titration. For experiments with increased K, NaCl or NMDG was replaced by equimolar KCl. All experiments were corrected for junction potentials, which were -18 mV for the NMDG solution and -10 mV for the Ringer solution. For most experiments with standard bath Ringer solution, 1 PM tetrodotoxin was added to the solution to block the endogenous Na+ current in the CHO cells. Most reagent salts and pharmacological blockers were obtained from Sigma. Fraction I of dendrotoxin (DTX-I) was purified bv HPLC as in Newitt et al. (1991) .
The' whole-cell variation of the patch-clamp technique was'used to record mKvl.1 K+ currents (Hamill et al., 1981) . Recording pipettes were constructed using a two-pull procedure from VWR micropipette glass (75 ~1). Dishes were mounted on the stage of a Nikon Diaphot microscope, and pipette manipulation was achieved using a Newport (Fountain Valley, CA) XYZ translator (with one motorized dimension) mounted on a holder for the Orbital Stage (Meridian Instruments, Kent, WA). Currents and voltages were recorded using an Axopatch 200 (Axon Instruments, Burlingame, CA), and currents were sampled on line and voltages delivered using an Atari STE computer, ITC 16 interface board, and M2Lab software (Instrutech, Elmont, NY). Current traces were not leak subtracted.
Results
Electrophysiological and pharmacological characteristics of mKvl.1 Outward potassium currents in CHO/MKl cells were recorded using a paradigm of stepping from a potential of -90 mV to between -60 and +60 mV for 500 msec. Current began to activate between -40 and -30 mV, and reached a maximum at +40 mV (Fig. 1A) . The activation time constant decreased with depolarization and ranged from 36 msec at -20 mV to 6 msec at +20 mV (mean of four cells). The mKvl.1 current inactivated little, although at the most positive potentials there was 5-8% inactivation at the end of the 500 msec pulse. The steady-state conductance was derived by dividing the average current over the last 30 msec of the pulse by the driving force (E -EK), and plotted in a conductance-voltage curve (Fig. 1 C ; n = 5). The curve can be fit by a Boltzmann function with a half-maximal voltage of -24.9 (k2.6) mV; the conductance changes e-fold in 6.3 (kO.5) mV. The steady-state inactivation curve was constructed by varying the holding potential of the cell for 7.5 set and stepping from that potential to + 30 mV to activate the remaining current (Fig. 1B) . A plot of this data ( Fig. 1 C , n = 5) shows that negative to -50 mV, no steady-state inactivation is seen. The maximal inactivation measured was 26% of the total current, from a holding potential of -10 mV, where considerable current is activated. This is consistent with the minimal degree of inactivation seen during 500 msec test pulses with mKv 1.1 (Fig.  1A) .
We have studied the sensitivity of mKvl.1 expressed in CHO cells to several K channel blockers (Fig. 2) . The block by 4-aminopyridine (4-AP) was half-maximal at 0.35 mM (n = 15). At higher concentrations of 4-AP (2-l 0 mM) an increase in leak was seen, and the effects of the 4-AP were difficult to reverse. Block by tetraethylammonium (TEA) was half-maximal at 0.5 mM (fit of n = 7 cells). DTX-I, a snake toxin, has been used as a biochemical probe to identify K channels from a variety of tissues as well as to purify K channels from mammalian brain (Rehm et al., 1989; Newitt et al., 1991) . DTX-I was tested for its blocking effects on mKv 1.1 channels and was shown to block of Neuroscience, December 1993, 13(12) 5245 reversibly, with a half-maximal value of about 2.5 nM (fit of n = 10 cells). At higher concentrations (25-50 nM), washing for approximately 30 min did not reverse the block by DTX-I. The ionic selectivity of mKv 1.1 was tested. Figure 3 shows tail current traces obtained after a pulse to +30 mV to elicit current, returning to potentials ranging from -110 to -20 mV. The left panel shows the tail currents in 2.5 mM external K, under which conditions the current reverses at -85 mV. In the same cell, the external K was raised to 25 mM, causing the currents to reverse at -35 mV. Three cells were tested in a similar manner, and the mean change was 49 mV, which is close to a shift of 57 mV that would be expected for an ideal K+ ionselective conductance.
Comparison of CHO/MKI
and CHOIAB-IMKI cells The CHO/AB-cell line was transfected with a plasmid encoding a mutant regulatory subunit of PKA that does not bind CAMP, and remains bound to the catalytic subunit (Clegg et al., 1987) . The CAMP-stimulated PKA activity in this CHO/ABcell line was less than 10% of that observed in parental CHO cells without the mutant subunit (Li et al., 1992) . A similar reduction of endogenous PKA activity has been observed in other cell lines expressing the same mutant regulatory subunit construct (Ginty et al., 199 1; Schecterson and M&night, 1991 subunit (CHO/MKl). However, the electrophysiological characteristics of the current were the same between the two groups of cells. Figure 4A shows the conductance-voltage curves for the two types of cells, with the CHO/MKl values shown as circles and the CHO/AB-/MKl values as triangles. The two curves were not significantly different; similar or greater shifts were observed within the same experimental group of cell lines as between different groups. Figure 4B shows the amount of current density present in each of three CHO/MKl or CHO/AB-/MKl cell lines, and for cell lines containing pZEM plasmid alone (B2, B4). The CHO/ AB-/MKl cells express on average 3.4 times the current density (in pA/pF) that is expressed in CHO/MKl cell lines. All three CHO/AB-/MKl current densities (Cl, C9, ClO) were significantly greater than the three CHO/MKl cells (E2, E3, E4; p < 0.001). Recordings from control cells [CHO (B2) or CHO/AB-(B4) cells transfected with control plasmid] showed no outward currents. It is interesting to note that all CHO/AB-/MKl cell lines had a smaller cell size, averaging 11.5 f 3.0 pF (n = 34) as compared to 17.0 f 4.6 pF (n = 35) in the CHO/MKl lines. Furthermore, all cell lines did express a TTX-sensitive sodium current, which was not changed in density between any of the cell lines (data not shown). An additional CHO/ABm/MKl cell line was recorded under the same conditions and found to express 30.1 pA/pF, increasing the average current density to 26 pA/pF, a 3.6-fold increase over the CHO/MKl lines. This cell line (C4) was not included in other experiments. RNase protection assays Seven sets of RNase protection assays were performed. Results from an experiment using the 5' probe (see Fig. 5B for plasmid structure) are shown in Figure 5 . An assay using the 3' probe gave similar results (data not shown). Figure 5A shows that no mKv 1.1 -specific protected fragment was detected using the 5' probe to examine the control cell lines B2 (CHO with pZEM alone) or B4 (CHO/AB-with pZEM alone). Additional control cell lines transfected with pZEM containing mKv 1.1 in the antisense orientation showed no mKv 1.1 mRNA expression (data not shown). In contrast, an mKv 1.1 -specific protected fragment was detected using either the 5' or the 3' probe to examine all six cell lines expressing mKv 1.1 (Fig. 5A) . The three CHO/MKl lines (E2, E3, and E4) have a lower level of specific mRNA expression, as determined by relative intensity on a phosphorimager scan, than the corresponding CHO/ABm/MKl cell lines Cl, C9, and ClO. Five of the seven RNase protection assays were quantitated by phosphorimaging analysis. In three of these assays we also quantified the levels of 18s RNA, expressing mKv 1.1 RNA relative to 18s RNA levels. The average increase in mKv1. l-specific RNA in the CHO/AB-/MKl lines relative to the CHO/MKl lines was 1.94 +-0.57 (p < 0.001). These results indicate that, at steady state, there is an increased level of mKv1.1 RNA in the cells containing the mutant regulatory subunit. This does not appear to be a general feature of RNA expression in these cells, as the RNA levels for 18s are not significantly different between the two cell types (average 18s density of C lines relative to E lines was 1.045, n = 2). We do not know ifthis increase in steady-state mKv 1.1 transcript levels is the result of changes in transcription rates or stability of the RNA (see Discussion).
The Journal of Neuroscience, December 1993, 13 (12) 5247 mKvl. I protein levels The 3.4-fold increase in mKvl.1 current levels in the CHO/ ABm/MKl cells (C lines) over the CHO/MKl cells (E lines) cannot be accounted for by taking only the twofold increase in mKv 1.1 RNA transcript into consideration. In order to explore further the mechanisms involved in upregulation of mKvl.1 current in cells expressing the mutant regulatory subunit of PKA, protein levels of mKv 1.1 were assessed using a polyclonal antisera specific to mKvl.1 ((Y-Kvl. 1; Wang et al., 1993) . Figure  6A shows an immunoblot (Western) in which total membrane protein from the indicated cell lines was probed with (Y-KV 1.1. A single major band of 55-65 kDa is detected first in the CHO/ MKl (E2, E3) and more strongly in the CHO/ABm/MKl cell lines (Cl, C9). The size of the recognized protein is somewhat larger than the predicted molecular weight of the unglycosylated mKvl.1 protein (56.4 kDa; Tempel et al., 1988) , suggesting that some glycosylation has occurred in the CHO cell lines. The band was not detected by preimmune sera or when a-Kv 1.1 sera were preincubated with mKv 1.1 peptide (data not shown), indicating that LY-KV 1.1 specifically detects the expressed mKv 1.1 protein.
Staining intensity of the 60 kDa region in each lane was measured by chemiluminescent detection and densitometric scanning; the results are graphed below the gel. Six such Western blots were analyzed. On average, the CHO/ABm/MKl cell lines (C lines) have a 2.8-fold increase in protein compared to the CHO/MKl cell lines (E lines; p < 0.00 1). The control cell lines, which are transfected with the pZEM plasmid only, showed no detectable mKvl.1 protein expression, consistent with their lack of mKv 1.1 current.
Immunoprecipitation experiments on metabolically labeled cells confirmed the finding that mKv 1.1 protein levels were increased in CHO/ABm/MKl cell lines (Fig. 6B ). Control and MKl -expressing cell lines were metabolically labeled with 35S-methionine for 20 hr, harvested, and immunoprecipitated with a-Kv 1.1. Precipitated proteins were separated by SDS-PAGE and analyzed by phosphorimaging. Consistent with the Western immunoblot data, the presumed mKv 1.1 band appeared in all lines transfected with mKv 1.1, was increased an average of 3.0-fold in the CHO/ABm/MKl lines (p < 0.001, n = 6) but was not detectable in cell lines transfected with control plasmid only. Quantitatively comparable data was obtained when the metabolically labeled samples were independently analyzed by Westem blot, indicating that steady-state levels of mKvl.1 protein were reached during the labeling period (data not shown). Thus, chronic inhibition of PKA activity leads to a significant increase in mKvl.1 protein assayed either by immunoblot or by immunoprecipitation.
Discussion
Using whole-cell recording techniques, we have observed that expression of the mKv 1.1 K channel gene in transfected CHO cells gives rise to a rapidly activating, sustained K+ current that activates at -40 mV and is sensitive to block by 4-AP, TEA, and DTX. These physiological and pharmacological characteristics are similar to those observed for rKv 1.1, the rat homolog of mKv 1.1, when it is expressed transiently in Xenopus oocytes (Stuehmer et al., 1988) . We also found that, in CHO cells, coexpression of mKv 1.1 with a plasmid encoding a dominant negative mutation of the regulatory subunit of PKA (AB-) causes an increase in mKv 1.1 K+ current density. Significant increases are seen in both mKv 1.1 RNA levels and protein levels.
These results suggest that the increased K+ current seen in the CHO/AB-/MKl cell lines relative to the CHO/MKl cell lines occurs by mechanisms that are posttranscriptional and may include regulation of RNA levels. These findings are distinct from the results of comparable studies on PKA regulation of Na channel expression (Ginty et al., 1992; Li et al., 1992) .
Several mechanisms might give rise to an increased current in the PKA-deficient cell lines. It is unlikely that PKA is affecting mKv 1.1 gene transcription in our system. While PKA has been shown to regulate transcription of various genes through the transcription factor CREB (Montminy et al., 1989; Habener, 1990) in our transformed CHO cell system, mKvl.1 expression is driven by the PKA-insensitive metallothionine-1 promoter in the ZEM plasmid. The mKv 1.1 gene endogenous to the CHO cell genome is apparently also insensitive to changes in PKA activity, as there was no induction of mKv 1.1 current in CHO cells where PKA activity was decreased in cells containing the plasmid control vector without the mKv1.1 insert (CHO/ABm line B4). Thus, the upregulation of mKv 1.1 RNA is more likely to occur by modification of PKA-sensitive gene products that may be involved in the processing, modification, or stabilization of functional mKv 1.1 RNA. Several examples of second messenger modulation of mRNA have been reported. In a rat hepatoma cell line, dibutyryl-CAMP increases the half-life ofmRNA for phosphoenolpyruvate carboxykinase by 1 O-fold, via a mechanism that does not require protein synthesis and that enhances the stability of the polysome-free mRNA (Hua and Hod, 1992) . In a cell line expressing corticotropin-releasing hormone, stimulation of protein kinase C by phorbol esters increases mRNA levels for this hormone, and also increases the length of the polyA tail of the mRNA by threefold (Adler et al., 1992) , thus leading to a possible, increase in mRNA stability due to an increased ability to bind to the polyA binding protein and protection from exonucleolytic digestion ). Although we do not know the specific mechanism by which mKv 1.1 RNA is increased in our system, it is unlikely that this increase alone (1.9-fold) could entirely account for the increase seen in current densities (3.4-fold) or protein levels (2.8-fold).
It remains possible that some portion ofthe increase in mKvl.1 current density is determined by PKA during translation, assembly, insertion, or function of the mKvl.1 channels. Phosphorylation of Na channels in excised patches using CAMP and PKA catalytic subunit causes a decrease in the Na+ current (Li et al., 1992) . In addition, using a strategy similar to the one used in the present study, coexpression of the mutant regulatory subunit of PKA in CHO cells causes upregulation of Na+ current, suggesting that the endogenous level of PKA activity in CHO cells is sufficient to modulate the level of Na channel expression. Unlike the situation with mKvl.1 K channels, Na channel mRNA levels are unchanged while Na channel-specific saxitoxin (STX) binding sites on the cell surface increase when PKA activity is reduced. These data suggest that inhibition of PKA causes Na channel number and current to increase via an unknown posttranscriptional mechanism (Li et al., 1992 ). In contrast, hormonally induced PKA activity in differentiating PC12 cells causes an increase in Na+ current (Kalman et al., 1990) . Recent studies (Ginty et al., 1992) indicate that this upregulation requires PKA activity at the posttranslational level: PC 12 cells transfected with a mutant regulatory subunit of PKA respond to hormone by relatively normal morphological differentiation, by increasing Na channel mRNA, and by increasing the number of STX-binding Na channels on the cell surface. However, no significant Na+ current is observed in any of the PC1 2 cells expressing the mutant regulatory subunit of PKA, suggesting that PKA activity is required posttranslationally to establish functional Na channels. Thus, chronic reduction of PKA results in the reduction of Na+ current in PC12 cells, an increase in Na+ current in transfected CHO cells, and a comparable but mechanistically unique increase in K+ current in our studies.
whether channel regulation requires direct phosphorylation of the channel protein.
In a few cell types, endogenously expressed delayed rectifiertype K+ currents have been shown to be functionally modulated by PKA In human T lymphocytes, stimulation with P-adrenergic agonists or CAMP directly modulate a K+ current, causing a decrease in peak current, an increase in inactivation during the pulse, a decrease in the voltage dependence of steady-state inactivation, and a negative shift in the current-voltage relation (Soliven and Nelson, 1990 ). This K+ current inactivates during a maintained pulse, has a K, for block of TEA of 8-l 6 mM, and resembles the n-type K channel found in lymphocytes (DeCoursey et al., 1987a) . This channel has been identified as MK3 or mKvl.3 (Grissmer et al., 1990 ; also called RGKS, Douglass et al., 1990 ) a channel closely related to mKvl.1. On a longer time scale, the n-type channel has also been shown to be upregulated by mitogenic stimulation in mouse T lymphocytes (DeCoursey et al., 1987b ) due, at least in part, to synthesis of new protein. Thus, this mKv 1.1 -related channel can be upregulated developmentally or downregulated when PKA activity is increased acutely. In our experiments, PKA activity was inhibited chronically, resulting in an increase in mKv 1.1 current.
In cardiac tissue, the effect of CAMP and of the catalytic subunit of PKA is to upregulate K+ current (Giles et al., 1989; Yakawa and Kameyama, 1990) . The molecular species of K channel modulated by adrenergic input, CAMP, and the catalytic subunit of PKA is not known in heart, and thus the molecular structure of the phosphorylation site is also unknown. It is possible that at least one of the K channels regulated by PKA in heart is not closely related to Shaker or to mKv 1.1. Specifically, a small (130 amino acid-encoding) cDNA, min-K, is expressed in cardiac tissue and induces a very slowly activating current, ZsK, when expressed in Xenopus oocytes (Folander et al., 1990) . The kinetics of activation and deactivation of the min-K-induced current resemble closely those recorded in several types of cardiac cells. Furthermore, the K+ current induced by min-K in oocytes is upregulated by PKA stimulation. This PKA stimulation, however, is not affected by a site-directed mutation of the putative PKA phosphorylation site in the expressed min-K cDNA (Blumenthal and Kaczmariek, 1992) . Instead, the upregulation seen in oocytes expressing min-K appears to be caused by insertion of new channels into the cell membrane.
We conclude from the literature that, depending on cell type being studied, changing cellular PKA activity can result in either increased or decreased channel expression and that this change can be brought about either directly or indirectly via transcrip-
